Phase II trial of etoposide in APUD tumors. Academic Article uri icon

Overview

abstract

  • Thirty-three patients with advanced, metastatic APUD tumors (islet cell, carcinoid, or medullary carcinomas of the thyroid) were treated with etoposide as a single agent. Of 29 evaluable patients, four (14%) had partial responses (95% confidence limits, 1%-26%). Toxic effects seen were those previously reported for etoposide as a single agent. Etoposide has activity in APUD tumors; further studies with this agent are indicated.

publication date

  • March 1, 1987

Research

keywords

  • Adenoma, Islet Cell
  • Carcinoid Tumor
  • Etoposide
  • Thyroid Neoplasms

Identity

Scopus Document Identifier

  • 0023140070

PubMed ID

  • 2434226

Additional Document Info

volume

  • 71

issue

  • 3